+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type

Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type

American Journal of Hematology 29(4): 183-188

Chronic lymphocytic leukemia of B-cell type (B-CLL) is a malignant disease characterized by monoclonal proliferation of small lymphocytes of B-cell origin, usually associated with suppression of polyclonal B-cell activation (i.e., proliferation and differentiation). Normal human B-cell proliferation is controlled by different T-cell-derived lymphokines, including interleukin 2 (IL2) and gamma interferon (gamma-IFN), that account for the majority of the B-cell growth factor (BCGF) activity produced by mitogen-activated peripheral blood mononuclear cells (PBMCs). We have previously shown an increased and dysregulated secretion of IL2 in peripheral blood from patients with B-CLL. BCGF, IL2, and gamma-IFN productions by phytohemagglutinin (PHA)-stimulated PBMCs were investigated in 13 patients with active untreated B-CLL and 11 healthy donors. B-CLL PBMCs produced a significant amount of BCGF (6 U/ml) despite the low percentage of T cells (10%) associated with this disease as compared with that found in healthy donors (61%). BCGF production in normal controls and B-CLL patients was tripled after irradiation of PBMCs or addition of indomethacin. gamma-IFN secretion in B-CLL patients was decreased when compared with normal controls. Therefore, when gamma-IFN was calculated per fixed number of T cells, production was significantly higher in B-CLL patients than in normal controls, showing a dilution of the productive cells. This study suggests that T cells from B-CLL patients are functional in terms of BCGF production despite their decreased percentage and abnormalities in surface markers.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 041081262

Download citation: RISBibTeXText

PMID: 3142255

DOI: 10.1002/ajh.2830290402

Related references

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. Blood 66(3): 614-619, 1985

Effects of interleukin 1 2 and gamma interferon on leukemic b cell colony formation in patients with b cell type chronic lymphocytic leukemia. Acta Haematologica Japonica 53(5): 777-782, 1990

Effects of interleukin-12 on interferon gamma production by peripheral blood and tumor infiltrating T-lymphocytes from renal cell carcinoma patients Evidence of impaired secretion. Journal of Urology 155(5 Suppl. ): 543A, 1996

Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma. Acta Haematologica Polonica 23(1): 29-41, 1992

Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro. Archives of Medical Research 40(5): 357-363, 2009

Interleukin 2 il 2 and gamma interferon gamma ifn production by peripheral blood lymphocytes in chronic liver diseases. Hepatology 7(5): 1144, 1987

The effect of cimetidine on peripheral blood lymphocytes from healthy donors and melanoma patients augmentation of t cell responses to t cell growth factor mitogens and alloantigens and of t cell growth factor production. Cancer Immunology Immunotherapy 21(2): 141-147, 1986

The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia. Haematologica 91(4): 574-576, 2006

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood 82(8): 2379-2385, 1993

Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake. Alcoholism Clinical and Experimental Research 21(7): 1226-1231, 1997

Long term production of interferon gamma ifn g tumor necrosis factor tnf and interleukin 2 il 2 by peripheral blood lymphocytes of patients with multiple sclerosis ms myasthenia gravis mg and other autoimmune diseases oad. FASEB Journal 6(4): A1048, 1992

Low dose recombinent interleukin 2 following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia , mantle cell , and follicular lymphoma. Blood 96(11 Part 2): 350b, 2000

Cell surface fibronectin on peripheral blood lymphocytes in normal individuals and in patients with acute and chronic lymphocytic leukemia and non Hodgkin's lymphoma. Allergologia et Immunopathologia 13(1): 35-40, 1985

High production of interferon-gamma but not interleukin-2 by human T cell lymphotropic virus type I -infected peripheral blood mononuclear cells. AIDS Research and Human Retroviruses 17(Suppl. 1): S 27, 2001

A comparison of conditions of interleukin 2 production between peripheral blood lymphocytes and leukemia cell line lymphocytes and leukemia cell line lymphocytes. Journal of the Chinese Society of Veterinary Science 19(3): 193-204, 1993